Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a Minnesota-based medical device company specializing in fully implantable hearing systems, including its Esteem device targeting patients with sensorineural hearing loss. The company entered public markets in 2023 through a business combination with Anzu Special Acquisition Corp I, a blank-check vehicle that completed its IPO in 2021 and was sponsored by Anzu Partners. Operating in the medical technology sector, Envoy Medical filed a DEFA14A — definitive additional proxy materials — with the SEC on September 2, 2026, signaling an active shareholder vote process. The company trades on Nasdaq under the ticker COCH and remains subject to standard SEC reporting obligations as a post-combination public issuer. Sign up at SpacDesk for the full filing history, institutional ownership data, and real-time proxy tracking for COCH and hundreds of other SPAC-derived companies.